SPONSOR
Gruppo Oncologico Italiano di Ricerca Clinica
Total Trials
2
Recruiting
2
Phases
Phase 3
NCT06548867
Recruiting
Retrospective Analysis of Patients With Metastatic Renal Cell Carcinoma Treated With CABOzantinib
Metastatic Renal Cell Carcinoma
NCT04996017 Phase 3
Recruiting
Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso)
Mesotheliomas Pleural